Utilidad de la escala ICH para el pronóstico de morbimortalidad en pacientes diabéticos e hipertensos de 45 años o mayores con hemorragia intraparenquimatosa en el Hospital Norte de Guayaquil Los Ceibos durante el periodo 2017-2019.

Abstract

Introduction: Intraparenchymal hematoma has been considered the third cause of mortality in our environment during the 2014 to 2019 term. The ICH scale is responsible for inquiring on the prognosis of morbidity and mortality to improve the patients’ quality of life. Objective: To determine the usefulness of the ICH scale for the prognosis of morbidity and mortality in 45 years old patients or older with intraparenchymal hemorrhage. Methodology: This is a cohort, analytical, observational study based on the population of diabetic and hypertensive patients who have suffered from intraparenchymal hemorrhage and that have been treated at the Hospital Norte de Guayaquil Los Ceibos during the 2017-2019 term. Results: A sample of 183 patients was obtained, in which those with the highest prevalence were males from 62 to 74 years old. The Glasgow scale ranged from 13 to 15 points in 50.8% of cases; 74.9% of the study population suffered from lesions at the supratentorial level. Regarding comorbidities, 59.6% had grade II hypertension, while 40.4% had DM. Around 91 patients died after suffering from this clinical entity. Conclusion: The mortality of the patients is high, affecting 1 out of every 2 cases of this pathology, being directly associated with the clinical factors of the ICH Scale, for which the scale is useful.